Dementia Alzheimers Clinical Trial
Official title:
Feasibility Study for the Use of Computer Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
This study will test G:DATA, a simple computer game designed to diagnose Alzheimer's Disease, in three different groups of people, some of whom have Alzheimer's Disease. It will look at whether the results of G:DATA match the results of tests that are used to diagnose people with Alzheimer's Disease now. The Investigators will also ask patients and healthcare staff for participant views on the G:DATA game.
Alzheimer's Disease is a type of dementia that causes progressive deterioration to memory, thinking and behaviour. It is currently thought to affect 50 million people globally, although 75% of those affected are thought to be undiagnosed, with no access to treatment.[2] Diagnosis requires extensive clinical evaluation, involving a range of techniques that are resource-intensive and can only be performed in clinical settings. Research has demonstrated a direct link between carefully designed spatial learning within computer games and the detection of deterioration in specific brain cells first affected by Alzheimer's Disease, overlooked by existing assessment techniques. This research will look at the feasibility of using a computer game diagnostic tool, called G:DATA, in the diagnosis of Alzheimer's Disease. It will do this by providing a clinical benchmark, consolidating the results of gameplay performance against current clinical gold-standard assessments, during a clinical study conducted with two patient groups (patients with Mild Cognitive Impairment (MCI), patients with mild AD-related dementia) and a healthy controls group. Outcomes will include validity data of the game's output in diagnosing Alzheimer's Disease, together with data on the tool's usability, and acceptability. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT03378245 -
Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations
|
N/A | |
Recruiting |
NCT04871698 -
On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs
|
||
Active, not recruiting |
NCT05847153 -
MASC: Reducing Stress for Caregivers
|
N/A | |
Recruiting |
NCT04863859 -
Persons With Dementia and Their Extended Family Caregivers
|
||
Active, not recruiting |
NCT05529277 -
Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein
|
||
Active, not recruiting |
NCT03631069 -
Detecting Dementia in the Retina Using Optical Coherence Tomography
|
||
Terminated |
NCT03682874 -
Identifying Novel Aging Targets for Treatment of Delirium
|
||
Completed |
NCT03907748 -
Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia
|
N/A | |
Completed |
NCT04058886 -
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
|
N/A | |
Not yet recruiting |
NCT05606445 -
Surface EMG to Measure Paratonia in Dementia
|
||
Recruiting |
NCT04308512 -
Care Coordination System for People With Dementia
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03943641 -
Dementia Risk Prediction Model: Development and Validation
|
||
Not yet recruiting |
NCT05245903 -
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
|
||
Not yet recruiting |
NCT06396377 -
Interest of the Reborn® Doll as a TO in the Care of Residents With Alzheimer's Disease or a Related Disorder
|
N/A | |
Recruiting |
NCT03472482 -
Optical Coherence Tomography in Cerebral Amyloidosis
|
||
Recruiting |
NCT04313582 -
Feasibility of the SmartPrompt for Improving Everyday Function in Dementia
|
N/A | |
Recruiting |
NCT05315895 -
The Dampness Syndrome of Chinese Medicine Cohort Study
|
||
Completed |
NCT04428112 -
Rural Dementia Caregiver Project
|
N/A | |
Completed |
NCT04462029 -
A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers
|
Early Phase 1 |